Free Republic 3rd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $17,298
21%  
Woo hoo!! And we're now over 21%!! Thank you all very much!! God bless.

Keyword: prempro

Brevity: Headers | « Text »
  • Breast Cancer Seen as Riskier With Hormone

    10/22/2010 7:44:01 PM PDT · by neverdem · 10 replies
    NY Times ^ | October 19, 2010 | DENISE GRADY
    Hormone treatment after menopause, already known to increase the risk of breast cancer, also makes it more likely that the cancer will be advanced and deadly, a study finds. Women who took hormones and developed breast cancer were more likely to have cancerous lymph nodes, a sign of more advanced disease, and were more likely to die from the disease than were breast cancer patients who had never taken hormones. The increased risks were relatively small and are not fully understood. But previous research has found that hormone treatment can cause delays in diagnosis by increasing breast density, making tumors...
  • HT Use Cut Tied To Cancer Decline (HT means hormone therapy. Breast cancer was studied.)

    02/14/2009 12:58:53 AM PST · by neverdem · 25 replies · 911+ views
    Family Practice News ^ | 15 January 2009 | BRUCE JANCIN
    SAN ANTONIO — Two new statistical analyses of Women's Health Initiative data persuasively indicate that the recent abrupt decline in breast cancer incidence in the United States is attributable to a dramatic drop in the use of estrogen-plus-progestin menopausal hormone therapy, and not—as skeptics have argued—to less utilization of mammography. Academic fencing over causality aside, the practical take-home message from the latest Women's Health Initiative (WHI) data analyses is that the breast cancer risk imparted by hormone therapy rises sooner and more steeply than previously recognized, and it swiftly declines after HT is discontinued, Dr. Rowan T. Chlebowski said at...
  • New study firmly ties hormone use to breast cancer (What a dumb title, as if there were some doubt?)

    12/13/2008 9:49:47 PM PST · by neverdem · 47 replies · 1,660+ views
    The International Herald Tribune ^ | December 13, 2008 | MARILYNN MARCHIONE
    Associated Press SAN ANTONIO: Taking menopause hormones for five years doubles the risk for breast cancer, according to a new analysis of a big federal study that reveals the most dramatic evidence yet of the dangers of these still-popular pills. Even women who took estrogen and progestin pills for as little as a couple of years had a greater chance of getting cancer. And when they stopped taking them, their odds quickly improved, returning to a normal risk level roughly two years after quitting. Collectively, these new findings are likely to end any doubt that the risks outweigh the benefits...
  • PROTECT YOUR RIGHT TO choose Bio-Identical Hormones

    03/20/2006 4:54:15 PM PST · by goodnesswins · 37 replies · 1,444+ views
    Key Pharmacy ^ | 3/20/06 | Key Pharmacy
    PROTECT YOUR RIGHT TO CHOOSE COMPOUNDED BIO-IDENTICAL HORMONE MEDICATIONS THE FACTS: Recently, Wyeth Pharmaceuticals, maker of Premarin & Prempro, (drugs derived from Pregnant Mares Urine – yes, horses pee) filed a Citizen’s Petition with the Food & Drug Administration (FDA) asking the FDA to impose harmful restrictions on the compounding and dispensing of Bio-identical hormone replacement therapy (BHRT). (Bio-identical hormones are manufactured to have the same molecular structure as the hormones made by your own body.) This petition would eliminate the availability of compounded bio-identical hormones, which are prescribed by healthcare providers and prepared by pharmacists, to meet the unique...
  • Class Certification in Fla. Prempro Suit Reversed (Mass Tort Alert)

    02/16/2006 9:48:48 PM PST · by chet_in_ny · 161+ views
    In a huge victory for pharmaceutical giant Wyeth, a Florida appeals court on Wednesday halted a class action suit that claimed its hormone replacement drug could harm hundreds of thousands of Florida women. A three-judge panel of the state's 3rd District Court of Appeal unanimously held in Wyeth Inc. v. Arlene Gottlieb that the claims were not common enough for the case to move forward as a class action. Instead, women who claim they may suffer future health problems because of their use of the drug Prempro will have to file individual suits against Wyeth. The Wyeth decision reverses a...